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Abstract 
The prevalence of Hepatitis B surface antigen (HBsAg) and Hepatitis C virus (HCV) was determined in the 
voluntary blood donors in Enugu, between April and December 2012. The blood donors were made up of 
students from different higher institutions in Enugu and also civil servants working in Enugu. A total of 290 
blood samples were screened for HBsAg and HCV by rapid test kits. The overall prevalent rate of HBsAg and 
HCV were 5.17% and 1.03% respectively. The prevalence rate of HBsAg and HCV was higher in male (6.28% 
& 1.35%) than the female (1.49%). The study showed that the prevalence rate of HBsAg was also higher in 
blood donors between the age range of 28- 37 (7.14%) than those between the age range of 18-27(4.90%). HCV 
was also higher in blood donors with age range of 28-37(4.76%) than those between the age ranges of 18-27 
years (0.41%). Hepatitis B surface antigen and HCV seropositivity were significantly associated with age, sex 
and states of origin of the blood donors (p<0.05). The prevalence of HBsAg in donors which are indigene of 
other states was 3.70% while indigene of Enugu state was 7.9%. HCV was found only on indigene of other 
states. Routine screening of blood donors for HBsAg and HCV are strongly recommended for blood donors in 
Enugu especially student in higher institutions.  
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1. Introduction 
The current blood banking system in Nigeria generally encourages non-remunerated or voluntary blood donation 
especially to relatives who are hospitalized. The serological screening for HBsAg, HCV in addition to HIV are 
now compulsory for all intending blood donors in most hospitals in Nigeria. Although in some parts of Enugu 
the blood transfusion service is still at its teething stage, is not yet fully equipped to cater for the extensive 
screening tests obtained elsewhere despite the high burden of viral infections among the people (Allain & 
Owusu-Ofori, 2006; Ekpo et al. 1995). HBsAg and HCV are still endemic in Nigeria with high prevalence in the 
blood donor population; blood transfusion may be one of the common means of transmitting these infections, 
especially in places where screening is not practiced (Bukbuk et al. 2005).  
Studies had shown that HBsAg and HCV infections have drawn global attention owing to their 
grievous public health impact (Muktar et al. 2005; Umolu et al. 2005). The carrier rate of HBV among black 
Africans is 10.4% and 15% in young volunteer blood donors. Nigeria in which Enugu state is part of it remains 
one of the most populous nations in Africa with hyper endemicity for HBV infection. The prevalence rate of 
HBsAg in the replacement blood donors ranges between 1.2 % - 26% and 2.4% in voluntary donors (Olokoba et 
al. 2009; Tribedi 1994).  Also prevalence of HBV varies between 2% in high income countries where the 
prevalence is low to 8% in low income countries where the infection is endemic with sex and age (Ejele et al. 
2005).  
HCV was first discovered in 1989 and in 1990 the antibody detection assay was introduced. Before 
1990, the majority of cases of HCV infection in the U.S.A. and Europe were acquired through I.V. drug use and 
transfusions. Before the discovery of adequate testing techniques for HCV infection, almost 10% of transfusion 
recipients acquired the infection. This made it one of the commonest causes of transfusion related hepatitis 
(Imoru et al. 2003; Dodd et al. 2002). HCV infection is still endemic in Nigeria with varying prevalence rate in 
the different geographical states. The prevalence of hepatitis C and the commonest mode of transmission among 
Nigerians are unknown, but recent studies across the country among blood donors show a prevalence ranging 
between 0.4% and 10.4% according to locality (Kaote et al. 2005).  Another study also reveals the prevalence 
rate of 0.5% to 12.3% (Olokoba et al. 2009). Yet, some centers in Nigerian have not started screening for anti – 
HCV before blood transfusion (Ahmed et al. 2007).  
Routine screening for hepatitis C in blood donors is only carried out in major public health institutions 
in Nigeria; because of unavailability of screening kits. This has caused a serious short and long term health 
implications on the populace; knowing very well that chronic hepatitis C is a progressive disease that leads to 
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death through hepatocellular carcinoma and also predisposes to renal cell carcinoma (Tong et al. 1995).  
Since the developmental status of a nation also reflects the health status of her people and the health 
status of all the voluntary blood donors in Enugu, this study was carried out to determine the prevalence of 
HBsAg and HCV among the voluntary blood donors in Enugu, southeastern Nigeria. 
 
2. Materials and Methods  
2.1 Study Area 
The study was carried out in the Department of Hematology and Immunology, Faculty of Medicine, Enugu State 
University of Science & Technology Enugu, Enugu State. Enugu State is one of the states in the eastern part of 
Nigeria. The state shares borders with Abia State and Imo State to the south, Ebonyi State to the east, Benue 
State to the northeast, Kogi State to the northwest and Anambra State to the west. The city is characterized by 
high level of environmental sanitation, moderate planned housing, portable water supply and proper management 
of wastes especially in the Enugu urban. 
2.2 Study population  
Two hundred and ninety voluntary blood donors are randomly selected during the National blood transfusion 
blood drive in the higher institutions in Enugu. The higher institution includes Enugu State University of Science 
& Technology, Institute of Management and Technology, Federal Cooperative College Oji River, Enugu State 
College of Education Technical, Enugu and Federal School of Dental Technology Enugu. All were screened for 
HBsAg and HCV by immunochromatographic method. This study was done from April 2012 to December 2012. 
2.3 Sample collection  
Three milliliters of venous blood (without anticoagulant) was collected aseptically from the intending blood 
donors. Sera were separated and stored frozen (-20oc) until required for assays.   
2.4 Detection of HBsAg and HCV  
Wondfo one step HBsAg test strips (manufactured by Guangzhou wondfo Biotech Co. Ltd; Wondfo Scientech 
Park, South China University of Technology, Guangzhou, P.R, China) was used for detection of HBsAg. It is a 
rapid immunochromatographic assay designed for qualitative determination of HBsAg in human serum. It is for 
in vitro diagnostic use with sensitivity of 96.2% and specificity of 99.3%. The test was performed and 
interpreted according to manufacturer’s specification. The test was also done based on this principle “Wondfo 
one step HBsAg serum/Plasma test strip is a rapid Immuno-chromatographic test for visual detection of hepatitis 
B virus surface antigen (HBs Ag) in serum/plasma samples. The membrane is pre-coated with anti-HBV anti-
bodies on the test line region of the strip. During testing, the specimen reacts with the particle coated with the 
HBV antibody. The mixture migrates upwards on the membrane chromatographically by capillary action to react 
with anti-HBV antibodies on the membrane and generate a colored line. Presence of colored line on the test 
region indicates positive result. A procedural colored line on the control line region will always appear to serve 
as control”. ANTEC Diagnostics products Ltd, manufactured by ANTEC Diagnostic Ltd, 4848 San Felipe road, 
block 150, San Jose, CA 95135, which based on the principle of double sandwich immunoassay was used for 
determination of anti-HCV in serum. The test was conducted using the stated principle “The HCV test strip is a 
rapid chromatographic immunoassay for the qualitative detection of anti-body to Hepatitis C virus in serum. 
During testing the specimen reacts with the protein-A coated particles. The mixture migrates upward on the 
membrane chromatographically by capillary action to react with recombinant HCV antigen on the membrane 
and generate a colored line. Presence of colored line indicates a positive result while its absence indicates a 
negative result. To serve as a procedural control, a colored line will always appear on the control line region 
showing that proper volume of specimen was added and membrane wicking occurred”. 
2.5 Data analysis:  
The data was analyzed statistically using SPSS computer software version 17.0 for windows to determine if there 
is any significant relationship between infection rate, state of origin of donors, gender and age. The prevalence of 
HBsAg and HCV infection was calculated by using donors with positive samples as numerator and the total 
number of donors enrolled as denominator. 
3. Results and Discussion 
Two hundred and ninety voluntary blood donors were recruited for this study. Out 290, 281(96.90%) of them are 
students schooling in Enugu, 8 (2.76%) are civil servants working in Enugu and 1 (0.34%) was self employed 
individual residing in Enugu. Out of 281 students, 189 (67.26%) are indigene of other states of Nigeria, while 92 
(32.74%) students blood donors are indigene of Enugu state. This study established the sero-prevalence of 
HBsAg and anti-HCV antibodies in 290 voluntary blood donors. In this study the overall sero-prevalence of 
HBsAg and HCV was 5.17% and 1.03% respectively.  The HBV infection rate of 5.17% in this study is however 
higher than 4.1% reported by (Ugwuja & Ugwu, 2010) among apparently healthy adolescents in Abakaliki; 2.5% 
reported by (Okonko et al. 2012) among blood donors in Ibadan, but lower than 7.0% reported by (Okonko et al. 
2012) among the attendees of ARFH center in Ibadan Nigeria. The prevalence of HBsAg was highest in blood 
donors between the age group of 28-37 years [3 (7.14%)] than those between 18-27 years [7 (4.90%)]. The same 
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applied to HCV. 
The result of table 1 showed the prevalence of HBsAg and HCV according to the age of the donors. 
Table 1: Age distribution of HBsAg and HCV among blood donors 
Age group NO tested (%) NO tested positive NO tested positive 
(years)  for HBsAg (%) for HCV (%) 
18-27 245 (84.48) 12 (4.90) 1 (0.41) 
28-37 42 (14.48) 3 (7.14) 2 (4.76) 
38-47 3 (1.03) 0 (0.00) 0 (0.00) 
Total 290 (100.00) 15 (5.17) 3 (1.03) 
Statistically, HBsAg and HCV sero-positivity were significantly associated with age group (p<0.05).  In this 
study the prevalence of HBsAg and HCV was higher in those aged 28-37 years than those aged 18-27 years. 
This is similar to previous studies which observed that HBsAg & HCV prevalence rate increases with increase in 
age (Okonko et al. 2012; Alao et al. 2009). This finding is in line with the new strategy adopted by the 
international community to recruit blood donors less than 30years of age to ensure provision of safe blood 
(WBDD (2007). The implementation of this policy has been shown to reduce the prevalence of HBsAg and 
HCV (Lawal et al. 2009). Meanwhile, in Nigeria, studies have shown that HCV infection is less prevalent 
compared to HBV (Jesse et al. 2008; Ojo et al.1990). Okonko et al reported 7.1% prevalence of HBsAg for age 
group 16-29 and 6.9% prevalence for 30years and above (Okonko et al. 2012). There is slight difference 
between the above study and the present study. 
The result of table 2 showed the prevalence of HBsAg and HCV according to the sex of the donors. 
Table 2: Gender distribution of HBsAg and HCV among the blood donors 
Sex NO tested (%) NO tested positive NO tested positive 
  for HBsAg (%) for HCV (%) 
Male 223 (76.90) 14 (6.28)  3 (1.35) 
Female 67 (23.10) 1 (1.49) 0 (0.00) 
Total 290 (100.00) 15 (5.17) 3 (1.03) 
In relation to sex, the prevalence of HBsAg was highest in male [14 (6.28%)] than the female counterpart [1 
(1.49%)]. The same applied to HCV. In this study gender distribution showed 6.28% prevalence for males and 
1.49% prevalence for females. There is significant association between gender and infection rate of HBsAg 
(p<0.05). This is similar to what Okonko et al reported and Udeze et al who reported high prevalence of HBsAg 
in males than female (Okonko et al. 2012; Udeze et al. 2012). The reason for higher prevalence rate of HBV 
among male may be due to multiple sexual partner rampart among men especially in the campus (Okonko et al. 
2012). Gender distribution showed 1.35% of HCV in males while female had none. The reason for this may be 
due to habits such as multiple sexual partners and intravenous drug use which is common in men (Lawal et al. 
2009). 
The result of table 1 showed the distribution of HBsAg and HCV according to the donor’s state of origin. 
Table 3: HBsAg and HCV prevalence according to the donor’s state of origin 
Donors State of origin NO of donor according NO positive NO positive 
 to their state of origin (%) for HBsAg for HCV (%) 
Lagos 1 (0.34) 0 (0.00) 1 (100) 
Kaduna 1 (0.34) 0 (0.00) 0 (0.00) 
River 2 (0.69)  0 (0.00 0 (0.00) 
Benue 26 (8.97) 2 (7.69) 1 (3.85) 
Anambra 46 (15.86) 1 (2.17) 0 (0.00) 
Delta 8 (2.76) 0 (0.00) 0 (0.00) 
Imo 47 (16.21) 0 (0.00) 0 (0.00) 
Akwaibom 1 (0.34) 0 (0.00) 0 (0.00) 
Ogun 1 (0.34) 0 (0.00)  0 (0.00) 
Ondo 1 (0.34) 0 (0.00) 0 (0.00) 
Kogi 1 (0.34 1(100)  0 (0.00) 
Enugu 101 (34.83) 8 (7.92) 0 (0.00) 
Edo 1 (0.34)   0 (0.00) 0 (0.00) 
Adamawa 1 (0.34) 0 (0.00) 1 (100) 
Cross River 11 (3.79) 0 (0.00) 0 (0.00) 
Abia 19 (6.55) 0 (0.00) 0 (0.00) 
Gombe 1 (0.34) 1 (100) 0 (0.00) 
Ebonyi 21 (7.24) 2 (9.52) 0 (0.00) 
Total 290 (100) 15 (5.17) 3 (1.03) 
Abbreviation 
NO= Number, %= percentage 
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The prevalence of HBsAg was highest in Enugu state indigene [8 (7.92%)] than the indigenes of other states [7 
(3.70%)]. HCV prevalence was seen among the indigenes of other states [3 (1.59%)]. Statistically, HBsAg and 
HCV sero-positivity were significantly associated with state of origin of the blood donors (p<0.05). This 
confirmed the results of other studies done in various parts of Nigeria showing that prevalence of HBsAg is still 
high in this country (Jeremiah et al 2008; Mustapha and Jibrin, 2004). The overall sero-prevalence of HCV in 
this study was 1.03%. This prevalence rate though low, confirmed that HCV infection is prevalent among 
healthy blood donors temporally residing in Enugu, Nigeria. It is lower than the prevalence rates of 5% and 12% 
reported in Port-Harcourt and Benin city respectively (Imoru et al. 2003).  Reason for lower prevalence rate in 
this study may be because more than 90% of the blood donors are youth and university student who take proper 
care of their health (Udeze et al. 2012). The result of this study showed that 1.59% prevalence of HCV was 
present only in blood donors that are indigene of other states of Nigeria while indigenes of Enugu had 0.00%.  
This shows that travelling from one state to the other is one of the factors that contribute to spread of HCV 
infection.   
 
5. Conclusion  
This study confirmed the presence of HBsAg and HCV among voluntary blood donors in Enugu State. The study 
shows that risk factors associated with significant of HBsAg and HCV seropositivity were age, sex and travelling 
from one state to another. This study also showed that resource limited country like  Nigeria are still lagging 
behind in term of achieving a remarkable reduction in HBsAg and HCV infection rate among our youth. There is 
need for general screening of HBsAg and HCV in all the student of higher institutions in Nigeria so that 
appropriate treatment will be commenced immediately.  
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